Mastocytosis presenting with mast cell‐mediator release‐associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features

BACKGROUND: Nonsteroidal anti‐inflammatory drugs (NSAIDs) are frequently avoided in mastocytosis, because of a potential increased risk for drug hypersensitivity reactions (DHRs) due to inhibition of cyclo‐oxygenase (COX), subsequent depletion of prostaglandin E (2) and release of leukotrienes. OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales: Rama, Tiago Azenha, Morgado, José Mário, Henriques, Ana, Escribano, Luis, Alvarez‐Twose, Iván, Sanchez‐Muñoz, Laura, Moreira, André, Romão, José, Órfão, Alberto, Matito, Almudena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967266/
https://www.ncbi.nlm.nih.gov/pubmed/35344302
http://dx.doi.org/10.1002/clt2.12132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967266/
https://www.ncbi.nlm.nih.gov/pubmed/35344302
http://dx.doi.org/10.1002/clt2.12132

Ejemplares similares